Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-19 Sale |
2023-09-21 5:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
20,000 | $12.67 | $253,400 | 739,688 (Indirect Direct) |
View |
| 2023-09-12 Purchase |
2023-09-14 4:25 pm |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
1,505,932 | $9.84 | $14,818,371 | 852,383 (Indirect Direct) |
View |
| 2023-08-31 Sale |
2023-09-05 9:08 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
25,000 | $10.26 | $256,600 | 1,120,742 (Indirect Direct) |
View |
| 2023-08-16 Sale(A) |
2023-09-05 4:05 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
15,000 | $10.14 | $152,100 | 1,023,714 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-17 5:00 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
15,000 | $10.14 | $152,100 | 1,145,742 (Indirect Direct) |
View |
| 2023-06-08 Sale |
2023-06-09 5:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
10,000 | $6.3 | $63,000 | 1,160,742 (Indirect Direct) |
View |
| 2023-06-05 Sale |
2023-06-07 9:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director |
10,000 | $6.17 | $61,700 | 1,170,742 (Indirect Direct) |
View |
| 2023-04-06 Purchase |
2023-04-07 4:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
10,000 | $0 | $0 | 396,197 (Direct) |
View |
| 2022-09-21 Purchase(A) |
2022-09-23 5:35 pm |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
20,000 | $0 | $0 | 74,279 (Direct) |
View |
| 2022-09-02 Purchase |
2022-09-06 4:26 pm |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
20,000 | $0 | $0 | 381,197 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-09-21 5:12 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner |
0 | $0 | 7,803,600 (Indirect) |
View |
| 2023-09-14 Other |
2023-09-14 4:25 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
99,556 | $0 | 852,383 (Indirect) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:14 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
21,520 | $0 | 7,420,805 (Indirect) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:36 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:34 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Moriarty John B EVP, Ch. Legal Officer & Sec. |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:32 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:31 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles Ch. Operating & Financial Off. |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:30 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Horn Kinney Chief Business Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:29 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO |
550,000 | $0 | 550,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:23 pm |
N/A 2033-01-31 |
Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Research Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-09-21 Option Award |
2022-09-22 6:51 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO |
20,000 | $0 | 74,279 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:16 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:15 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:13 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:12 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:10 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:08 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:06 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:32 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:30 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:29 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:28 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:27 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:25 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |